1. Home
  2. Browse
  3. National Institutes of Health
  4. RFA-HL-26-016

RFA-HL-26-016National Institutes of HealthR33

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Deadline
· 40d
Award ceiling
$350,000
Awards
Not stated
Posted
Nov 22, 2024

Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.

Summary

This Notice of Funding Opportunity (NOFO) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases. […]

Other topics in this solicitation7

Opportunity numbers beginning RFA-HL-26-, open now, soonest deadline first.

Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

RFA-HL-26-012National Institutes of Health9 review criteria on file

· 32d

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

RFA-HL-26-017National Institutes of Health4 review criteria on file

· 40d

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

RFA-HL-26-018National Institutes of Health4 review criteria on file

· 40d

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

RFA-HL-26-020National Institutes of Health4 review criteria on file

· 40d

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

RFA-HL-26-019National Institutes of Health4 review criteria on file

· 40d

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

RFA-HL-26-002National Institutes of Health6 review criteria on file

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

RFA-HL-26-003National Institutes of Health6 review criteria on file

The rest of this announcement — free with an account

  • The full announcement text, not the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement
  • Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
  • What similar funded projects received, from 219,000 past awards

No card required. Browsing and your first match are free.

More from National Institutes of Health

More in cardiovascular

Source record: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-016.htmlVia nih_guide+grants_gov. Last checked against the source . Always confirm dates with the funder.